Skip to main content
Equibles

Irenic Capital Management LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1929389 NEW YORK, NY
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$46,936,116
+$2,125,930 QoQ
Shares Held
2,760,948
0.0% QoQ
Ownership
5.32%
of shares outstanding
% of Portfolio
3.48%
of 13F equity value
Holder Rank
#5
of 179 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Irenic Capital Management LP holds $51,691,288 across 2 Biotechnology names. TBPH ranks #1 (90.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TBPH
Theravance Biopharma, Inc.
This page 		2,760,948 $46,936,116
2 ANAB
Anaptysbio, Inc
 70,447 $4,755,172

All Filings in TBPH

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,936,116 2,760,948
2026-03-31 $44,810,186 2,760,948
2025-12-31 $51,657,337 2,760,948
2025-09-30 $40,309,840 2,760,948
2025-06-30 $30,453,256 2,760,948
2025-03-31 $24,655,265 2,760,948
2024-12-31 $25,980,520 2,760,948
2024-09-30 $22,253,240 2,760,948
2024-06-30 $23,412,839 2,760,948
2024-03-31 $24,765,703 2,760,948
2023-12-31 $31,033,055 2,760,948
2023-09-30 $23,826,981 2,760,948
2023-06-30 $28,575,811 2,760,948
2023-03-31 $29,989,920 2,764,048
2022-12-31 $19,084,513 1,700,937